SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-058390
Filing Date
2017-11-13
Accepted
2017-11-13 16:33:12
Documents
69
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv477679_10q.htm 10-Q 575743
2 EXHIBIT 31.1 tv477679_ex31-1.htm EX-31.1 9562
3 EXHIBIT 31.2 tv477679_ex31-2.htm EX-31.2 9200
4 EXHIBIT 32.1 tv477679_ex32-1.htm EX-32.1 4811
  Complete submission text file 0001144204-17-058390.txt   4870458

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20170930.xml EX-101.INS 1031110
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20170930.xsd EX-101.SCH 55867
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20170930_cal.xml EX-101.CAL 47501
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20170930_def.xml EX-101.DEF 322830
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20170930_lab.xml EX-101.LAB 396875
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20170930_pre.xml EX-101.PRE 369381
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 171196416
SIC: 2834 Pharmaceutical Preparations